Hakan Gürvıt

TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis

Gernot Kleinberger, Yoshinori Yamanishi, Marc Suárez‐Calvet et al. · Science Translational Medicine · 2014 · 837 citations

Life Sciences, Cell Biology, Neuroscience +13

Using Exome Sequencing to Reveal Mutations in TREM2 Presenting as a Frontotemporal Dementia–like Syndrome Without Bone Involvement

Rita Guerreiro, Ebba Lohmann, José Brás et al. · JAMA Neurology · 2013 · 386 citations · Full text

Life Sciences, Genetics, Neurology +17

Comparative analysis of event-related potentials during Go/NoGo and CPT: Decomposition of electrophysiological markers of response inhibition and sustained attention

Elif Kirmizi-Alsan, Zübeyir Bayraktaroğlu, Hakan Gürvıt et al. · Brain Research · 2006 · 237 citations

Life Sciences, Neuroscience, Psychology +17

The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease

Erdinç Dursun, Duygu Gezen‐Ak, Haşmet Hanağası et al. · Journal of Neuroimmunology · 2015 · 230 citations

Medicine, Immunology, Neurology +17

BDNF, TNFα, HSP90, CFH, and IL-10 Serum Levels in Patients with Early or Late Onset Alzheimer's Disease or Mild Cognitive Impairment

Duygu Gezen‐Ak, Erdinç Dursun, Haşmet Hanağası et al. · Journal of Alzheimer s Disease · 2013 · 185 citations

Life Sciences, Neurology, Neuroscience +17